Table 1.
Characteristics of the study population.
| Parameters | Datasets | ||
|---|---|---|---|
| Training and validation of EAT-Net (n = 386) | Visual evaluation of EAT-Net (n = 1400) | Testing of EAT-Net and Crop-Net combined (n = 25) | |
| Demographics | |||
| Female, n; % | 187; 51.5% | 719; 51.3% | 14; 66% |
| Age in years | 58 (54–62) | 58 (54–61) | 58 (55–60) |
| Anthropometrics | |||
| Weight in kg | 82.6 (70.4–92.7) | 78.2 (68.4–89.4) | 78.8 (65.2–87.9) |
| Height in cm | 171 (164–178) | 172 (165–179) | 172 (166–176) |
| Waist circumference in cm | 98 (88–106) | 93 (84–101) | 92 (76–104) |
| Hip circumference in cm | 103 (98–109) | 102 (97–107) | 103 (94–109) |
| Cardiometabolic risk factors | |||
| Current smoking, n; % | 60; 15.5% | 151; 10.8% | 5; 20% |
| Systolic blood pressure in mm Hg | 123 (114–135) | 120 (110–132) | 118 (114–128) |
| Diastolic blood pressure in mm Hg | 75 (69–81) | 72 (66–80) | 72 (67–79) |
| Antihypertensive medication, n; % | 92; 23.8% | 245; 17.5% | 5; 20% |
| Cholesterol in mmol/l | 5.7 (5–6.4) | 5.5 (4.9–6.2) | 5.6 (5.1–6.4) |
| LDL in mmol/l | 3.8 (3.0–4.4) | 3.6 (3.1–4.3) | 3.6 (2.9–4.5) |
| HDL in mmol/l | 1.6 (1.3–2) | 1.6 (1.3–2) | 1.8 (1.5–2.2) |
| Triglycerides in mmol/l | 1.1 (0.81–1.6) | 1 (0.76–1.5) | 1.1 (0.73–1.6) |
| Cholesterol lowering medication (n; %) | 92; 23.8% | 96; 6.9% | 2; 8% |
| Blood glucose in mmol/l | 5.7 (5.3–6.1) | 5.5 (5.2–5.9) | 5.7 (5.3–5.9) |
| HbA1c in mmol/mol | 35 (33–38) | 34.5 (32.8–37) | 35 (33–37) |
| hsCRP in mmol/l | 1.4 (0.66–2.8) | 0.97 (0.54–2) | 0.98 (0.54–2.8) |
| Creatinine in mmol/l | 79 (69–88) | 78 (69–88) | 74 (68–83) |
Continuous numerical variables are represented with their median and, in brackets, interquartile range.